about
Chlamydia pneumoniae exacerbates aortic inflammatory foci caused by murine cytomegalovirus infection in normocholesterolemic miceInvolvement of a p53-dependent pathway in rubella virus-induced apoptosis.Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection.Fast vaccine design and development based on correlates of protection (COPs).Development of a cytomegalovirus vaccine: lessons from recent clinical trials.Chronic infections and atherosclerosis.Immunization of Chlamydia pneumoniae (Cpn)-infected Apob(tm2Sgy)Ldlr(tm1Her)/J mice with a combined peptide of Cpn significantly reduces atherosclerotic lesion development.Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapyHigh-level cellular and humoral immune responses in Guinea pigs immunized intradermally with a heat-inactivated varicella-zoster virus vaccineThe interactions between human dendritic cells and microbes; possible clinical applications of dendritic cells.Human cytomegalovirus induces stage-specific embryonic antigen 1 in differentiating human teratocarcinoma cells and fibroblasts.Human cytomegalovirus latency is associated with the state of differentiation of the host cells: an in vitro model in teratocarcinoma cells.The surface antigen phenotype of human embryonal carcinoma cells: modulation upon differentiation and viral infection.Differentiation of human embryonal carcinoma cells induces human immunodeficiency virus permissiveness which is stimulated by human cytomegalovirus coinfection.Immune responses to isolated human cytomegalovirus envelope proteins.Protection of Chinese painted quails (Coturnix chinensis) against a highly pathogenic H5N1 avian influenza virus strain after vaccination.Impact of multiple antigenic epitopes from ApoB100, hHSP60 and Chlamydophila pneumoniae on atherosclerotic lesion development in Apob(tm2Sgy)Ldlr(tm1Her)J mice.Adjuvant modulation of the immune response of mice against the LcrE protein of Chlamydophila pneumoniae.Genotyping of Chlamydia trachomatis from the endocervical specimens of high-risk women in Hungary.Inflammatory- and immune responses in relation to bacterial replication in mice following re-infections with Chlamydophila pneumoniae.Expression of bacterial genes and induction of INF-gamma in human myeloid dendritic cells during persistent infection with Chlamydophila pneumoniae.Chronic infections and histamine, CRP and IL-6 levels after percutaneous transluminal coronary angioplasty.Chronic infections and genetic factors in the development of ischemic stroke.A soluble factor(s) released by MRC-5 cells early and late after human cytomegalovirus infection induces maturation of monocyte-derived dendritic cells.Elevated antibody levels against Chlamydia pneumoniae, human HSP60 and mycobacterial HSP65 are independent risk factors in myocardial infarction and ischaemic heart disease.Infection of U937 monocytic cells with Chlamydia pneumoniae induces extensive changes in host cell gene expression.Chlamydophila (Chlamydia) pneumoniae induces histidine decarboxylase production in the mouse lung.Association of Chlamydia pneumoniae with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin.Chlamydia pneumoniae in atherosclerotic middle cerebral artery.Independent and joint effects of antibodies to human heat-shock protein 60 and Chlamydia pneumoniae infection in the development of coronary atherosclerosis.Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10.Progress in vaccine development for prevention of human cytomegalovirus infection.Vaccines for the prevention of human cytomegalovirus infection.Characterization of multiple molecular interactions between human cytomegalovirus (HCMV) and human immunodeficiency virus type 1 (HIV-1).The effect of supraoptimal temperature on the multiplication of different cytomegalovirus strains.Effect of arginine deficiency on the reproduction of human cytomegalovirus.Virus-specific changes in mouse cells inoculated with a strain of human cytomegalovirus.Latent infection of mouse cells with human cytomegalovirus.Expression of the human cytomegalovirus genome in mouse cells and in human-mouse heterokaryons.Cytomegalovirus-induced membrane antigens in productively infected cells.
P50
Q28362988-A115BCC6-F351-440E-9D39-BB44DBE8B2A9Q33864542-A82DBA9E-97E4-493E-8030-4F89418DB105Q34004010-EA7FAA9B-A3FD-4252-B79A-37AFDD908D47Q34291098-6F4252FE-71F6-403A-8C84-0192D9F5FC78Q34451960-E35C08F3-FF9A-4CD4-B27B-54CEEBFB2FA9Q34494185-13247A23-9A38-4A60-9AFA-25E2A44A3EC7Q35069480-51B5FF87-8491-4891-A96F-81C39EB22FE5Q35232341-58F409E0-F5C6-4934-A935-9B728124A792Q35548072-E8FA6B79-76D5-4DA5-9141-CBBA9F331502Q35954319-2387F8AC-DBC8-4DF1-AC0B-8A0442B67652Q36356039-9B9E313E-7F97-48B4-830A-79260F57CDAEQ36363938-DFEF0347-B260-4EA2-913A-AF18EB442409Q36444941-4F11F1C4-20FE-4526-9DD3-DF45E10B5019Q36689261-A1BF4F9F-626A-46F4-860D-1DF2B9121FF5Q36863167-12504F8F-5BEB-4713-9C36-1048EB7649BCQ37316060-5F8CEE57-5C7E-4A7B-8771-CEED1204CA3EQ37848119-40A09BB7-80F2-4B57-A88B-AEA3637582EBQ37855003-2A050D1A-8E2D-4308-92C5-B10C59440A12Q37855042-9CFD6030-FEFF-477D-A761-153226350FBAQ37857387-8BC117E9-D902-4F67-8321-70DCD9D4E424Q37857929-72D65B89-5D81-4BBC-A33D-A114ED168368Q37859036-E79D31BE-446F-4369-BBF0-99E78A23767CQ37859096-25BF4121-AF9F-46C7-ABBA-9EC4842A04C3Q37862068-532092B4-C821-462F-B144-9F2F1A8FC198Q37867424-1A0F17E4-556F-4513-9D5F-D7B79D318E57Q37868327-AF7AFA6E-420A-444D-9D91-1547882A724BQ37868415-52BB8D3C-671B-43F0-87DD-A2E745C18E40Q37871349-E4880EF7-EFF4-4676-BCC8-955E0AE69CF8Q37873484-55C6C72A-706B-43E3-8929-0011B49258B4Q37874609-70EA9C46-BB6C-418E-97BA-967FDF7AC1D7Q37876614-CE2923A6-E829-4DC4-94FC-F9C1332ADD47Q37879805-34D7E392-7067-4EBE-8CD1-1D660B944CC2Q37897939-20161842-46E8-433C-87CF-65EBF93299EBQ38341000-53748AFD-3EF3-44B2-BAD4-BE835B375766Q39917528-701BB094-8D86-452D-BF37-D05725499092Q39945634-E24DF6D2-3DB4-43DA-9577-53F190F00066Q39945646-57894A29-87F4-4A67-8CCE-5B07D35579C3Q40031514-94C98326-6386-465C-99C1-C89B61E2F90DQ40062924-E81AFEEB-A6F6-4464-81C5-FCF5397D2876Q40115558-8D058847-1078-4794-B51E-47537BCA6CFC
P50
description
(1936) magyar orvos, mikrobiológus
@hu
name
Eva Gönczöl
@en
Eva Gönczöl
@sl
Gönczöl Éva
@hu
type
label
Eva Gönczöl
@en
Eva Gönczöl
@sl
Gönczöl Éva
@hu
altLabel
E Gonczol
@en
E Gönczöl
@en
E. Gonczol
@en
E. Gönczöl
@en
Eva Gonczol
@en
Gonczol E
@en
Gonczol E.
@en
Gonczol
@en
Gönczöl E
@en
Gönczöl E.
@en
prefLabel
Eva Gönczöl
@en
Eva Gönczöl
@sl
Gönczöl Éva
@hu
P19
P21
P27
P31
P3973
P569
1936-09-28T00:00:00Z